Compare · NH vs VRSN
NH vs VRSN
Side-by-side comparison of NantHealth Inc. (NH) and VeriSign Inc. (VRSN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NH and VRSN operate in EDP Services (Technology), so they compete in similar markets.
- VRSN is the larger of the two at $25.79B, about 290.1x NH ($88.9M).
- VRSN has hit the wire 9 times in the past 4 weeks while NH has been quiet.
- VRSN has more recent analyst coverage (6 ratings vs 0 for NH).
- Company
- NantHealth Inc.
- VeriSign Inc.
- Price
- $1.96-32.41%
- $283.28-3.93%
- Market cap
- $88.9M
- $25.79B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 1998
- News (4w)
- 0
- 9
- Recent ratings
- 0
- 6
NantHealth Inc.
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
VeriSign Inc.
VeriSign, Inc., together with its subsidiaries, provides domain name registry services and internet infrastructure that enables internet navigation for various recognized domain names worldwide. It enables the security, stability, and resiliency of internet infrastructure and services, including providing root zone maintainer services, operating two of the 13 internet root servers; and offering registration services and authoritative resolution for the .com and .net domains, which support global e-commerce. VeriSign, Inc. was incorporated in 1995 and is headquartered in Reston, Virginia.
Latest NH
- SEC Form 15-12G filed by NantHealth Inc.
- NantHealth Inc. filed SEC Form 8-K: Leadership Update
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- NantHealth Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
Latest VRSN
- Exec. Chairman, Pres, & CEO Bidzos D James sold $981,646 worth of shares (3,300 units at $297.47), decreasing direct ownership by 0.75% to 439,339 units (SEC Form 4)
- EVP, Gen Counsel & Secretary Indelicarto Thomas C sold $146,725 worth of shares (500 units at $293.45), decreasing direct ownership by 1% to 37,051 units (SEC Form 4)
- Director Armstrong Courtney D bought $4,929 worth of shares (16 units at $305.81), increasing direct ownership by 0.26% to 885 units (SEC Form 4)
- Counterfeiters Stole an Estimated $500K From One Brand -- Now This NASDAQ Apparel Stock Is Building the AI That Fights Back
- VeriSign Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- EVP, Chief Financial Officer Calys John covered exercise/tax liability with 179 shares, decreasing direct ownership by 0.56% to 31,842 units (SEC Form 4)
- EVP, Gen Counsel & Secretary Indelicarto Thomas C covered exercise/tax liability with 706 shares, decreasing direct ownership by 2% to 37,496 units (SEC Form 4)
- EVP - Technology & CSO Mcpherson Danny R covered exercise/tax liability with 726 shares, decreasing direct ownership by 2% to 34,470 units (SEC Form 4)
- Exec. Chairman, Pres, & CEO Bidzos D James covered exercise/tax liability with 1,646 shares, decreasing direct ownership by 0.37% to 442,490 units (SEC Form 4)
- EVP - Technology & CSO Mcpherson Danny R sold $1,355,106 worth of shares (5,000 units at $271.02), decreasing direct ownership by 12% to 35,195 units (SEC Form 4)